Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue - Other
Ratios

Perspective Therapeutics (CATX) Receivables - Net (2016 - 2025)

Perspective Therapeutics' Receivables - Net history spans 15 years, with the latest figure at $179000.0 for Q3 2025.

  • For Q3 2025, Receivables - Net fell 17.51% year-over-year to $179000.0; the TTM value through Sep 2025 reached $179000.0, down 17.51%, while the annual FY2024 figure was $116000.0, 90.04% down from the prior year.
  • Receivables - Net for Q3 2025 was $179000.0 at Perspective Therapeutics, down from $225000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $2.1 million in Q1 2022 and bottomed at $78000.0 in Q1 2025.
  • The 5-year median for Receivables - Net is $1.2 million (2022), against an average of $1.1 million.
  • The largest YoY upside for Receivables - Net was 58.45% in 2025 against a maximum downside of 92.19% in 2025.
  • A 5-year view of Receivables - Net shows it stood at $1.6 million in 2021, then decreased by 17.24% to $1.4 million in 2022, then fell by 14.53% to $1.2 million in 2023, then plummeted by 90.04% to $116000.0 in 2024, then skyrocketed by 54.31% to $179000.0 in 2025.
  • Per Business Quant, the three most recent readings for CATX's Receivables - Net are $179000.0 (Q3 2025), $225000.0 (Q2 2025), and $78000.0 (Q1 2025).